Teva Pharmaceuticals - Wikipedia
Articles about Teva Pharmaceuticals, Inc.
Teva Pharmaceuticals has acquired success with Actavis Generics | World Finance
Teva to pay $225 million to settle cholesterol drug price-fixing charges | The Times of Israel
Teva Is the 23rd Drug Maker to Impose Limits on 340B Contract Pharmacies - 340B Report
Suffering from missteps, drugmaker Teva struggles to heal own ills | The Times of Israel
A Drug Company Wagers the U.S. Won't Dare Charge It With Crimes - The New York Times
What does Teva's growth strategy look like?
Teva reaches proposed $4.35 bln settlement of U.S. opioid lawsuits | Reuters
Teva Pharmaceuticals - Wikipedia
Teva donates potential coronavirus treatment to hospitals across the US - The Jerusalem Post
Teva Pharmaceutical Industries Ltd. Company Profile - Market.us
Teva ponies up $420M to settle with investors who said company hid price-fixing scheme | Fierce Pharma
Israel's Teva to move US HQ from Pennsylvania to New Jersey | The Times of Israel
Teva to Close Missouri Plant, Report Says | Ctech
Teva profit plummets, stock slides | Ctech
Teva to Acquire Mexico's Rimsa for $2.3 Billion - WSJ
New York court dismisses most of Teva claims against Mexican drugmakers | The Times of Israel
Teva plans massive layoffs; Overland Park office's future unclear - Kansas City Business Journal
Unveiling Teva Pharmaceutical Industries (TEVA)'s Value: Is It Really Priced Right? A ...
Israeli drug manufacturer Teva at center of anti-trust lawsuit brought by 44 states - Jewish Telegraphic Agency
Teva Pharmaceuticals found to be responsible for its role in the opioid epidemic in New York State | CNN
Israeli drug company Teva reaches $4.3 billion settlement in US opioid lawsuits | The Times of Israel
Teva's $420mn investor settlement to be mostly covered by insurers | The Insurer
Teva hi-res stock photography and images - Alamy
Teva Pharmaceutical to Nominate Four New Directors - WSJ
Teva & Barr Get Super-Sized
Teva Pharmaceuticals | LinkedIn
Closure of another criminal case will help Teva's new CEO to focus on return to growt | Ctech
